Scientific Review Council
The Scientific Review Council (SRC) oversees the peer review of all cancer research applications submitted to CPRIT. Members of the SRC chair the cancer research peer review committees. The SRC must assess the evaluations completed by the cancer research peer review committees and create a final list of proposals recommended for CPRIT grant awards. This list is submitted to CPRIT's executive director. Texas law affords great weight to the review council’s funding recommendations, requiring the executive director’s final recommendations for funding awards to be “substantially based” on the list submitted by the review council.
Phillip A. Sharp, Ph.D.
Dr. Sharp earned a B.A. degree from Union College, KY in 1966, and a Ph.D. in chemistry from the University of Illinois, Champaign-Urbana in 1969. He did his postdoctoral training at the California Institute of Technology. In 1974, he joined MIT's Center for Cancer Research (now the David H. Koch Institute for Integrative Cancer Research). He received the 1993 Nobel Prize in Physiology or Medicine for his discovery of split genes. In 1978, Dr. Sharp co-founded Biogen (now Biogen Idec), and in 2002 he co-founded Alnylam Pharmaceuticals, an early-stage therapeutics company. He has received several awards, including the National Medal of Science for Biological Sciences, and he is an elected member of the National Academy of Sciences, the Institute of Medicine, the American Academy of Arts and Sciences, and the American Philosophical Society.
